|
CONSUMER NEWS RECALLS COMPLAINT FORM SCAM ALERTS |
| Small Claims Guide | Class Actions | Lemon Law | FAQ | Resources | Newsletters | Spanish | |
|
|
![]() |
Studies Allege Bayer Was Too Slow Withdrawing Baycol |
||||||
|
November 22, 2004
Merck has been under fire recently for allegedly moving too slowly to withdraw the arthritis drug Vioxx, which has been found to raise the risk of heart attack and stroke in some patients. In an editorial accompanying the article, JAMA's editors said it is time to recognize that the Food and Drug Administration (FDA) is unable to protect the public from dangerous drugs and to establish a new agency to fill that role. "It is unreasonable to expect that the same agency that was responsible for approval of drug licensing and labeling would also be committed to actively seek evidence to prove itself wrong," the editors wrote. Last week, David Graham, a senior FDA safety officer told a Senate panel that at least five dangerous drugs are on the market today because of the FDA's inability to effectively monitor drugs once they have been approved. The study cited in the JAMA article said that today's cholesterol-lowering statin drugs are very safe but can pose risks when taken with fibrates, drugs often taken by older patients with diabetes to lower triglycerides. Report Your Experience
|
||||||
Back to the top | |
|||||||
|
Home |
Rogues Gallery |
Good Guys |
Complaint Form |
News |
Recalls |
Search |
Site Map |
FAQ |
|
Advertisement
Terms of Use Your use of this site constitutes acceptance of the Terms of Use
Copyright © 2003-2008 ConsumerAffairs.com Inc. All Rights Reserved. |
|